Provided by Tiger Fintech (Singapore) Pte. Ltd.

GeoVax Labs Inc

0.8200
0.0000
Post-market: 0.8179-0.0021-0.26%18:02 EDT
Volume:1.08M
Turnover:872.00K
Market Cap:20.63M
PE:-0.25
High:0.8500
Open:0.8400
Low:0.7810
Close:0.8200
Loading ...

GeoVax Reports 2024 Year-End Financial Results and Provides Business Update

NewMediaWire
·
28 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Mar

Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now

GlobeNewswire
·
26 Mar

BRIEF-GeoVax Labs Inc - Enters Placement Agency And Securities Purchase Agreements With A.G.P./Alliance Global Partners - SEC Filing

Reuters
·
26 Mar

GeoVax Labs Inc - Enters Placement Agency and Securities Purchase Agreements With a.g.p./Alliance Global Partners - SEC Filing

THOMSON REUTERS
·
26 Mar

GeoVax Labs Inc expected to post a loss of 77 cents a share - Earnings Preview

Reuters
·
26 Mar

GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

NewMediaWire
·
24 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar

GeoVax to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025

NewMediaWire
·
17 Mar

GeoVax to Present at the 37th Annual Roth Conference

NewMediaWire
·
11 Mar

Registration is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event MPOX 2025: Navigating the Global Public Health Emergency Featuring GeoVax CEO On March 6, 2025

NewMediaWire
·
04 Mar

GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy

NewMediaWire
·
03 Mar

GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International Concern

NewMediaWire
·
28 Feb

GeoVax Labs Is Maintained at Buy by D. Boral Capital

Dow Jones
·
28 Feb

GeoVax Labs Inc expected to post a loss of 77 cents a share - Earnings Preview

Reuters
·
25 Feb

GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health Preparedness

NewMediaWire
·
24 Feb

Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply Diversification

NewMediaWire
·
19 Feb

GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public Health

NewMediaWire
·
18 Feb

GeoVax to Present at the Emerging Growth Conference on February 19, 2025

NewMediaWire
·
17 Feb

GeoVax Congratulates Dr. Valerie Montgomery Rice on Receiving the 2025 Healthcare Champions Lifetime Achievement Award

NewMediaWire
·
11 Feb